The natriuretic peptide family, including A-type, B-type, and C-type peptides, plays a key role in the neuroendocrine regulation of the cardiovascular system and natriuresis.
The discovery of the natriuretic peptide family was a breakthrough in modern cardiovascular physiology as it provided a direct link between the heart and the kidneys in the regulation of natriuresis. Along with vasopressin and the renin-angiotensin-aldosterone system, the natriuretic peptides comprise the key peptides on which our present understanding of neuroendocrine regulation of the cardiovascular system is based. Three natriuretic peptides have been identified; the A-type, B-type and C-type natriuretic peptides. The former two, the A- and B-type natriuretic peptides, function mainly in the cardiovascular system and comprise the cardiac natriuretic peptides. Together with our increased understanding of the neurohormonal regulation of the cardiovascular system in recent years, the discovery of the natriuretic peptide family was important in the establishment of the new field of cardiovascular endocrinology.
Toru Suzuki (Wed,) conducted a review in Cardiovascular physiology. Natriuretic peptides was evaluated. The natriuretic peptide family, including A-type, B-type, and C-type peptides, plays a key role in the neuroendocrine regulation of the cardiovascular system and natriuresis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: